Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients

Transplantation

Volumn 78, Issue 1, 2004, Pages 112-116

  Hörnsten, Rolf ^a   Wiklund, Urban ^a   Olofsson, Bert Ove ^a   Jensen, Steen M ^a   Suhr, Ole B ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amyloid; Arrhythmia; FAP; Holter; Liver transplantation

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CONTROLLED STUDY; DISEASE SEVERITY; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART CONDUCTION; HEART RHYTHM; HOLTER MONITORING; HUMAN; HUMAN TISSUE; LETHALITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RECORDING; RISK; SWEDEN;

ADULT; AMYLOID NEUROPATHIES, FAMILIAL; ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POINT MUTATION; PREALBUMIN; SWEDEN;

EID: 4143094997     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000133517.20972.27     Document Type: Article

References (31)

1. Saraiva M, Costa P, Birken S, et al. Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans Assoc Am Physicians 1983; 96: 261.
2. Benson M. Amyloidosis. In: Scriver CR, Beaudet AK, Sly WS, et al, eds. The metabolic and molecular basis of inherited disease. New York, McGraw-Hill 1995, p. 4159.
3. Connors LH, Richardson AM, Theberge R, et al. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid 2000; 7: 54.
4. Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952; 75: 408.
5. Steen L, Holmgren G, Suhr O, et al. Worldwide survey of liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid Int J Exp Clin Invest 1994; 1: 138.
6. Holmgren G, Ericzon BG, Groth CG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 341: 1113.
7. Suhr OB, Herlenius G, Friman S, et al. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 2000; 6: 263.
8. Holmgren G, Steen L, Ekstedt J, et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991; 40: 242.
9. Adams D, Samuel D, Goulon-Goeau C, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000; 123: 1495.
10. Bergethon PR, Sabin TD, Lewis D, et al. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996; 47: 944.
11. Rydh A, Suhr O, Hietala SO, et al. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. Eur J Nucl Med 1998; 25: 709.
12. Anan I, El-Salhy M, Nyhlin N, et al. Liver transplantation restores endocrine cells in patients with familial amyloidotic polyneuropathy. Transplantation 2000; 70: 794.
13. Ando Y, Ando E, Tanaka Y, et al. De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation. Transplantation 1996; 62: 1037.
14. Olofsson BO, Backman C, Karp K, et al. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy. Transplantation 2002; 73: 745.
15. Garcia-Herola A, Prieto M, Pascual S, et al. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant. Liver Transpl Surg 1999; 5: 246.
16. Dubrey S, Davidoff R, Skinner M, et al. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997; 64: 74.
17. Stangou AJ, Hawkins PN, Heaton ND, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998; 66: 229.
18. Beckman A, Bjerle P, Olofsson B. Electrocardiographic findings in familial amyloidotic polyneuropathy. Am J Noninvas Cardiol 1992; 6: 192.
19. Olofsson BO, Backman C, Boman K. Echocardiographic assement of the course of heart disease in familial amyloidotic polyneuropathy. Am J Noninvas Cardiol 1988; 2: 300.
20. Myerburg RJ, Kessler KM, Luceri RM, et al. Classification of ventricular arrhythmias based on parallel hierarchies of frequency and form. Am J Cardiol 1984; 54: 1355.
21. deFreitas F. The heart in Portuguese amyloidosis. Postgrad Med J 1986; 62: 601.
22. Sawayama T, Kurihara T, Araki S. Noninvasive cardiovascular findings in familial amyloid polyneuropathy. Br Heart J 1978; 40: 1288.
23. Eriksson A, Eriksson P, Olofsson BO, et al. The cardiac atrioventricular conduction system in familial amyloidosis with polyneuropathy. A clinico-pathologic study of six cases from Northern Sweden. Acta Pathol Microbiol Immunol Scand A 1983; 91: 343.
24. Yazaki M, Tokuda T, Nakamura A, et al. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 2000; 274: 702.
25. Atkison P, Joubert G, Barron A, et al. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. Lancet 1995; 345: 894.
26. Roberts CA, Stern DL, Radio SJ. Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. Transplantation 2002; 74: 817.
27. Dollinger MM, Plevris JN, Chauhan A, et al. Tacrolimus and cardiotoxicity in adult liver transplant recipients. Lancet 1995; 346: 507.
28. Hawkins PN, Richardson S, MacSweeney JE, et al. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression. Q J Med 1993; 86: 365.
29. Westermark P, Sletten K, Johansson B, et al. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A 1990; 87: 2843.
30. Ando Y, Yonehara T, Tanaka Y, et al. Early pacemaker implantation in patients with familial amyloidotic polyneuropathy. Muscle Nerve 1996; 19: 1640.
31. Ando Y, Suhr OB. Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid 1998; 5: 288.